4-(2,4-dioxoimidazolidin-1-yl)benzoic acid, 95.0%, 25g

6-Methoxyquinoline-4-carboxylic acid, 95.0%, 5g

(E)-2-Cyano-3-(4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indol-7-yl)acrylic acid, 98+%, 10mg

6-Aminopyridazin-3(2H)-one, 95.0%, 25g

(R)-2-Amino-hexanedioic acid, 98.0%, 100g

2-Thiophenecarboxamide, N-[2-(4-chloro-2-methylphenoxy)ethyl]-, 500mg

Glass vials with rolled rim, 20 ml, Height, 70 mm, 200 Piece(s)

(11bS)-4-Hydroxy-2,6-bis(2,4,6-triisopropylphenyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 250mg

L-Alanine Benzyl Ester p-Toluenesulfonate>98.0%(HPLC)(T)25g

tert-Butyl (1R*,4R*)-4-(1-oxoisoindolin-2-yl)cyclohexylcarbamate, 1g

1,4-Dimethyl-2-nitrobenzene, 95.0%, 25g

4-Benzyloxybenzhydrazide, 98.0%, 25g

N-(2-phenylethyl)cyclohexanamine hydrochloride, 95.0%, 1g